Letters
Multidisciplinary team meetings
Having both patient advocates and patients at the MDT meeting might be useful
BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5285 (Published 08 October 2015) Cite this as: BMJ 2015;351:h5285- Ceinwen Giles, director1
- 1Shine Cancer Support, London, UK
- ceinwen.giles{at}gmail.com
Eigenmann’s recommendation that patients’ advocates attend the multidisciplinary team (MDT) meeting, not patients themselves, is interesting.1
Of those patients with cancer who know what an MDT is, many do not understand why they cannot attend a meeting at which they will be discussed. And many patients do not even understand what an MDT is. When you’re first diagnosed …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.